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Liposomal phosphatidylserine inhibits tumor cytotoxicity of liver 
macrophages induced by muramyl dipeptide and lipopolysaccharide 
Tons Daemen ~ Joke Regts. Gerrit L. Seherphof 
C,~min~c'n Utre "ht InMaltteJ~r Dnlg E~lTIor itiort ~GUIDE) l~lboralt~ ¢!t'Phv~l¢,logi al Chemist~3". Uml'e'rsita" o Gr mingot ,4ntlroni cs 
Deu~iptghl~n 1. 9713 A V Grotti~rg~'t~, Tflc ?.¥tht'rftmds 
Received 24 ['.lay 19tJr; revised 5 August 19t)6: ~lvcepted 6 August 1996 
Abstract 
Liposomes can very efficiently deliver imlnunomodulators to macrophages so as to induce tumor cytotoxicity, 
Liposomes most widely used I'~,r that purpose contain negatively charged lipidx, in particular phosphatidylscrine I, ps), to 
enhance liposome uptake by the macrophages. We investigated the eft~:ct ,,~f three negatively charged liposomal lipids Oil the 
in vitro activation of liver macrophages to tumor cytotoxieity by muran'tyl dipeptide (MDP) and lipopolysaccharide (LPS'L 
Both MDP- and LPS-induced tumor cytotoxicity towards n]urinc colon adenncarcinoma cells w~'re slrongly inhibited by 
PS-containing liposomes. Under comparable conditions phosl~hatidylglycerol (DPPG)-containing or dicetyl phosphate 
(DCP)-containing liposome~, dis not inhibit or only marginally inhibited the induction of tumor cytotoxicity. We did not 
observe PS-mediated inhibition of tumor cell toxicity when the exposure of the macrophages Io PS-liposomes was limited t,~ 
the 4-h activation period prior to addition of the tumor target cells, su~'~csting that the inhibitory effect is accomplished t~t 
the level of the later stages of the activation process. Previously. v,,e shorted th:n macrophages which are activated to tumor 
eytntoxicity during a 24-h incubation ,.,.'ith MDP become refractory to a second activation with MDP. Now we observed that 
simultaneous incubation with PS-containing liposomcs partially prevents Ibis refractoriness, which is also compatible with 
an interfering action of PS at a relatively late stage in the activation process. We conelnde thai PS, despite its, reported 
stimuiatory eftEct on liposome uptake by macrophages, can seriously antagonize the effectiveness of immunomodulating 
agents acting on macrophages. This bears relevance to the use of PS-colnaining litrosomes as a vehicle for such agents. The 
results are discussed in perspective of earlier reported phamlacological e fleets t~f PS and its metabolites. 
Kevword.~: Phosphatidylserine: Tumor cymtoxicity: Cytotoxicity; Muramyl dipeptide: Lipnpolysaccharide: Lil~lSOme; lvlacrophage: 
(Liver) 
1. Introduction 
Abbreviatilms: MDP. h:uramyl dipeptide: LPS, lipopoly- 
saceharide: PS, phnsphalidylsenne: DPPG, phosphatidylglycerol: 
DCP. dicetyl phosphate; FCS, telal calf serum; PC. phosphatidyl- 
choline; [~H]CE. [3H]cholestery[ oleyl ether; [*H]Thd. [meth31 
~H]thymidine; POPC, palmitoyloleoylphc~phatidylcholine: 
DOPS, dioleoylphosphatidylserine. 
• Corresponding author. Fax: +31 50 3632728, 
Macrophages can be activated to kill tumor cells. 
Activation can be achieved by exposing macrophages, 
including Kupffer cells, to a variety of immunomodu- 
lators such as mm~myl peptides, lipopolysaccharide 
(LPS). lymphokines and r-interferon [ I-3].  In vivo. 
however, muramyl dipeptide (MDP) cannot activate 
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PII SO005-2736(96)00164 2 
220 7~ Daemen et tll. / Bivchimh'a et Bioph.~ica Acre 1285 (1~96~ 219-228 
macrophnges to tumor cytotoxicity, presumably due 
to its rar,~, renal excretkm [4]. but upon encapsuhnion 
of the MDP in liposomes, the drug is able to cause a 
significant reduction of hepatic or pulmonary 
metastatic tumor growth in mice [5-7], The lipo- 
somes presumably act by efficiently delivering the 
MDP to tissue macrophages, which are the primury 
target of these vesicles upon i.v. or i.p. injection. A 
widely used and commercially available liposomal 
MDP preparation consists of phosphalidylcholine and 
phosphatidylserine i  a 7:3 molar ratio. In our at- 
tempts to optimize the level of liver maerophage 
activation by treatment with lipost)me-encapsulated 
immunomodulators, we investigated the effects of 
different liposomal lipids, in casu the negatively 
charged constituents and cholesterol, and observed 
some remarkable difl~rences, 
2. Materials and methods 
2.1. Anhnals 
Specific-pathogen-~q'ee female Wistar or male 
Wag/Rij rats (Harlan CPB, Zeist, The Netherlands), 
weighing 160-180 g, 7-9 weeks of age. were used in 
all experiments. 
2.2. Materials 
All cultures were grown in RPMI-1640 from Gibco 
and supplemented with 2 mM L-glutamine (Flow 
Labs.), penicillin Q (100 units/ml), streptomycin 
( 100 /xg/ml) (both from Gist-Brocades), and heat-in- 
activated fetal calf serum (FCS; Gib:"~). LPS from 
Escherichia colt 0127:B8 was purchased from IDifco 
Lab. MDP and placebo liposcmes (palmitoyl- 
oleoylphosphatidylcholine (POPC) and dioleoylphos- 
phatidylserine (DOPS) in a 7:3 molar ratio) were 
generous gifts from Ciba Geigy, Basel. MDP was 
stored desiccated at 4°C. DNase (grade 11) was pur- 
chased fi'om Roehringer, Mannheim. Egg phc~s- 
phatidylcholine (PC, L-ce-lecithin fi'om egg yolk), di- 
palmitoylphosphatidylglyccrol (DPPG) and PS from 
bovine brain were from Avanti Polar Lipids: choles- 
tcrol (chol) and dicctyl phosphate (DCP) were pm~ 
chased l'rc~m Sigma Chemicals Co., Lid, 
[~It]cholesreryl oleyl ether ([3H]CE, spec. act. 1.71 
TBq/mmol) and [meth.vl-3H]thymidin~ ' ([3H]Thd, 
spec. act. 185 GBq/mmol) were from Amersham. 
2.3. Tumor cell culture 
C26 colon adenocarcinoma ceils, syngeneic with 
BALB/c mice were grown as a monolayer in culture 
medium containing 10% FCS at 37°C in a humidified 
atmosphere with 5% CO, in air. 
2.4. Preparation of liposomes 
Multilamellar vesicles were prepared as follows. 
The lipid solutions in chloroform/methanol 9:1 were 
~tored under nitrogen at - 20°C. Lipids with or with- 
out [~H]CE (18.5 KBq [3H]CE/,o.mol of lipid) were 
mixed, dried under reduced nitrogen pressure, dis- 
solved in eyclohexane, and lyophilized. The lipids 
were then hydrated in pyrogen-free 135 mM NaCl-tO 
mM 4-(2-hydroxyethyl)- l-plperazineethanesulfouic 
acid (pH 7.4) and mechanically agitated for l0 mix at 
room temperature. 
For MDP-liposomes the lipids were hydrated in 
pyrogen-free 135 mM NaCI-10 mM 4-(2-hydroxy- 
ethyt)-l-piperazineethanesulfonic acid (pH 7.4) con- 
taining 1.7 ttg/ml MDP. The latter vesicles were 
sized by extrusion through two polycarbonate mem- 
branes (Nuelepore) of 0.4 ,urn pore diameter. Vesi- 
cles containing MDP were freed from nonencapsu- 
luted material on a Sephadex G-100 column (Phar- 
macia). The encapsulated amount of MDP was deter- 
mined with a galactosaminc determination assay [8] 
with a minor modification, i e., addition of 1% of 
Triton X-100 to the reaction mixture to destroy the 
liposomes. Liposome preparations were stored under 
nitrogen at 4°C and used within 1 day after prepara- 
tion. The lyophilized placebo liposomes from Ciba 
Geigy were hydrated with phosphate-buffered saline 
and vortexed for 30 s. These liposomes were stored at 
4°C and used within I month. 
2.5. Isoknion of rat l iter macrophages 
Liver macrophages were isolated by pronase diges- 
tion of the liver and pnrified by centrifugal elutriation 
as described befure [I], This procedure results in a 
90% pure macrophage population, based on Giemsa- 
and non-specific esterase staining. Contaminating 
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cells are mostly liver endothelial cells. Liver 
macrophages (25- 104 per well) in 200 #l of culture 
medium containing 10% FCS were seeded in 96-;',ell 
microtiter plates (Costar). The cultures were main- 
tained at 37°C in a humidified atmosphere containing 
5% CO,_ in air. 
2.6. Target cell radiolabeling 
Target cells in exponential growth phase were 
radiolabeled by a 20-h incubatkm in medium contain- 
[ng [3H]dThd as described before [I]. 
2.7. In t'itro cytolrtic assay 
Macrophage-mediated cytolysis was assessed by a 
[~H]dThd-release assay. The macrophages ",','ere incu- 
bated with the immunomodulators and the liposomes 
as described in the results. Subsequently 10 a 
[3H]dThd-labeled target tumor cells were added to 
the macrophages in monolayer culture. Radiolabeled 
target cells were also plated alone, as an addilional 
control. 44 h after the addition of tumor cells, the 
supematants were collected and radioactivity was 
measured in a liquid-scintillation counter. Specific 
cytolysis was calculated as follows: 
a-b  
% specific eytolysis = 100 x c - . .~% 
in which a is dpm in the supematant of target cells 
cocultured with test macrophages, b is dpm in the 
supematant of target cells eocultured with control 
macrophages, and c is dpm in the total amount of 
target cells added per well. The amount of radioactiv- 
ity released from target cell':, cultured with or without 
eomrol macrophages was always less than lOC/b of the 
amount of radioactivity added to each well. 
2.8. Phagocvtosis of liposomes 
One day after cell isolation, macrophage monolay- 
ers were incubated with liposomes containing [ ~ H]CE. 
as a metabolically inert marker, in lhe presence of 
10% FCS. After 24 h the medium was removed, the 
wells were washed 4 times with cold phosphale- 
buffered saline, and the cells were lysed with 0.5 M 
NaOH. Aliquots were taken for the determination of
protein content and radioactivity. Radioactivity data 
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were converted to nmot of liposomal ipid, based on 
the specific activity of the liposome preparations 
used. 
2.9. Statixtic,I olltll)sis 
The two-tailed Student's t-test was used to deter- 
mine statistically significant differeuces between 
groups 
3.  Results 
3. I, Effect of liFosomal lipids on MDP ~md LPS-in- 
",hl¢'ed ttlmor Q'totoxic actieity of liver macrophages 
Addition of liposomes (500 nmol lipid/roll con- 
taining 20-40 reel% of PS significantly affected the 
"rable I
Efl~ct t i t  lipos~,nxes onMDP-induced nlacvophage lumor cytotox- 
icily 
Lipo~ome Lipid dpm in supernatant 
composRiOll" ratio t% cytolysis) h~ 
Expl. I u Expl. 2 " 
MDP. no lipostbmes 382+ 5(33) 676+ 6a (43) 
eggPC/PS 9:1 381_+14(33) 522_+67(31) " 
eggPC/PS 8:2 259±35(19) " 342+41)(16) " 
¢ggPC/PS 7:3 N.D. 333+23 (15) " " 
cggPC/PS 6:4 212_+ 15 t145 " " 214_+48(5) " " 
POPC/DOPS 7:3 319_+ 6 [26l ' • 4214- 9 [22) ' 
eggPC/chol/PS 4:5:1 381 + 18 (335 459_+ 24125} " 
eggPC/chol/PS 3:4:3 251+12(18)'" 363±29(175" 
eggPC/cht~l/DCP 4:5:1 46,1 _+45 (415 " 66,2_+47 (42) 
cggPC/DPPG 7:3 406_+ 19 (36l 576_+38(355 
+ Per we l l  25  lU  ~ l i ver  macmphoges  were  incubalcd wah MDP 
(ula ,~/mll  in cllmhination with empty llpu~.~lnes conlposed of 
different [iplds [5110 mn•l nf lipid/ml). 104 [~H]dThd-]abeled 
C26 cells wen: added per well. 
h Atter 48 h ~H-release into Ihe medium was determined in 
triplicate between parenthesis the % of cvtolysi~; i~given. 
' dpm presented asmean±S.D. 
,I Expl. I, medium release: 88+_20 dpm: 10* C26 ceils add~ 
per :',,ell containing: 989_+ 85 dpm. 
ExpL 2, medium release: 150±28 dpm; It); C2h cells added 
per well containing: 1369_+42 dpm. 
Significanlly different ~ < 005) from cytolysis induced by 
MDP thine 
• " ,qignificanlly ditTerent (P < 0.(K)I) from cytolysis induced 
b~ MDP alorle, 
Table 2 
E]tecl ol liposumes on LPS induced macrophage tumor cytotoxi- 
cd~ 
Liposome Lipid dpm in ~upernatant 
composition " ratio (c,~ eytol;,sis) I~,~ 
Expt. I d Expt. 2 : 
LPS, no liposomes sn5 ±4n (80) 11964-_21(86) 
eggPC/PS tkl 806 + 59 (80) 950_+ 20 (66) " ' 
eggPC/PS 8:2 641--28(61) ' 604+_34(37) " '
eggPC/PS 7:3 N.D, 577 + 28 (35) " " 
eggPC/PS 6:4 401+26(35) " " 445+20(24) "" 
POFC/DOPS 7:3 544.+14(51) "" 601+79(37) "" 
eggPC/chol/PS 4:5:1 722_+76(70) 702_+ 30 (45) * " 
eggPC/chol/PS 3:4:3 487+31 (44) * * 468+48(26) ' " 
eggPC/chol/DCP 4:5:1 894+_55(89) 1i99_+27(86) 
eggPC/DPPG 7:3 774. j_ 29 (76) 1082 + 27 (77) " 
" Per well 25. IP* liver macrophages were incubated with LPS 
(100 ng/ml) in combination with liposomes composed of differ- 
ent lipids (50(I nmol of lipid/rol), lit 4 [~H]dThd-labeled C26 
cells were added per well. 
h After 48 h 3H-release into the medium was determined in 
triplicate, between parenthesis the % of cylolysis is gi;,en. 
dpro presented ~ mean_+S.D. 
a Expt. I, medium release: 88_+2(I dpm; lU z C26 cells added 
per well containing: 989 +_ 85 dpm. 
Expt. 2. medium release: 150±28 dpm: 104 C26 cells added 
per well containing: 1369+_42 dpm. 
• Significantly difl~renl (P < 0J)S) from cytolysis induced by 
LPS aioIle. 
• " S;gnificautly dif['erent (P <0.(Xtlt f[om cytolysls induced 
by LPS al~pe 
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amount incorporated in the l iposomes had to be 
l imited to 10%• due to its detergent properties which 
prevent the formation of  l iposomes at higher concen- 
trations. 
3.2. Effect of  PS concentration 
Macrophages were incubated with 100 / tg /ml  of  
MDP or 100 ng /ml  o f  LPS in combination with 
l iposomes containing 10 to 40  mol% of PS (Figs. 1 
and 2). Each l iposome formulation was added in two 
amounts: 0.25 /.tmol total lipid per ml (open sym- 
bols) or 0.5 pmol otal lipid per ml (f i l led symbols). 
As shown in Figs. 1 and 2, the extent of  MDP-  and 
LPS-induced tumor cell lysis was determined not 
only by the absolute amount of  PS but also by the 
tool fraction of  PS in the liposomes. It should be 
noted that these results refer to the amounts of  PS in 
the medium and not to amounts of  PS taken up by the 
macrophages (see also the following two sections, 
Section 3.3, 3.4). 
The levels of cytotoxicity observed vary between 
experiments (Table I vs. Fig. 2). This is inherent to 
extent of  tumor cell lysis induced by MDP and LPS 
(Tables I and 2. respectively). The effect of  lipo- 
some-incorporated cholesterol• often applied to im- 
pr(we l iposome stability, was not consistent. Whi le 
no significant effect of cholesterol was observed on 
the MDP- induced cytotoxieity, it showed a tendency 
to er~ance the inhibitory effect of PS on LPS-in- 
duced cytntnxicify. 
Lipo~:c.mes in which PS was replaced by DPPG or 
DCP. bt;th als,,) negatively charged, did not influence. 
or only slightly, tumor cell lysls. It'= Experiment 2 
(Tables I and 2) l iposomes containing 30 mnl% of 
DPPG inhibited tumor cell lysis induced by LPS, but 
not by MDP.  However, the extent of  inhibition was 
much lower than that induced by liposomes; contain- 
ing 30 mol% of PS. In contrast, in Experiment l ,  
DCP-containing l iposomes slightly enhanced MDP 





,o  , ,  
26 SO 75 100 125 150 I?S 200 225 
hmot Itposomal PS I ml 
Fig. I. Inhibition of MDP induced tumor ¢ytoloxiclty by PS-lipo- 
somes: P=~ dose response. Liver macrophages were cocuhured 
wilh ~H-labeled tumor ceils in the presence of IO0 pg/ml  of 
MDP alone (• )  or in corobination with lipo~omes, Open sym- 
bols represent I),~i~ induced in the presence of 0,25 #mol/ml of 
liposomal ipid and filled symbols lysls induced in the presence 
of 0,5 .~mol/nll of liposomal ipid. Four liposumc preparations 
~'ere used composed of eggPC/PS in ratios (It I 9:1 (©,Q), 8:2 
I [], l l  ), 7:3 ( A. • ) and 6:4 [ ~'. • ). After 48 h ~H-release into 
the supernatanl ~as determined in triplicate, Given is the mean 
percentage of cylolysis. Bars, S.D. " significamly different (p < 
0.0025) from cylnlysis induced by MDP aklne (•  45.2%). 
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SO 
2O ~ I 
0 25 5O 75 100 125 150 13'5 20O 2~5 
nmol llposomal PS J ml 
Fig. 2. Inhibition of LPS induced lumur c~toloxicily b3 PS-lipo- 
somes; PS-dose response. Liver mzlcr(~phages ~ere cocullured 
with xl-I-labelcd lumtlr cell+ ill the presence t)f Inn ng/in[ ol L LPS 
alone (~') or in combirtatiOll with [iposomes. Ft+r turther delails 
see legend to Fig. 1. " significantly difl~rent ( Y < (I.01)251 titml 
cytolymis nduced by I+PS alone t • ; 47.5f;-) 
this type of experiments, due to variations in intrinsic 
properties of individual macropha~c preparations attd 
fluctuations in tumor cell sensitivity. The experiments 
described were performed over a period of severed 
months. 
Activation of liver macrophages ,,,,'as also snbstan- 
tially inhibited by PS when liposome-entmppcd rather 
than free MDP was used to activate the cells (Fig. 3). 
Four liposome preparations were used with increas- 
ing mol fractions of PS. Each preparation revealed a 
clear tendency towards increasing inhibition with in- 
creasing liposome (Le.. PS) concentration. Further- 
more, for nearly all points representing the MDP in 
the 20%-, 30%- and 40%-PS lipnsomes (squares and 
triangles), the levels of cytotoxicity were significantly 
lower lhan those induced by the MDP in the corre- 
sponding lipid doses of the IO%-PS liposomes 
(circles). 
3.3. Efft, c'l of  lipid composition on the nplttke of 
liposomes by liter macrophages 
When comparing the inhibitory effects of different 
liposome compositions, it should be taken into con- 
sideration that liposomes of different composition 
will be taken up to different extents by the 
macrophages. In these experiments we determined 
the uptake of liposomes composed of egg PC with 10 
mol~,~ PS. 30 tool% PS or 30 tool% DPPG Fig. 4 
shows the uptake of these liposomes by cuhured liver 
macrophages after incubation for 24 h at 37°C. 
The association of PC /PS  (7:3) liposomes with 
macrophages was 2-3-fold higher than that of 
PC /DPPG (7:3) liposomes and 10-fold higher than 
that of PC /PS  (9:1) liposomes. At 4°C uptake values 
were only 10 -25% of the amount associated at 37°C 
(not shown), suggesting that the larger part of the 
radioactivity recovered from the macrophages at37°C 
is intracellnlar. 
3,4. b!flueme of the amount (~" macrophage-asgoci- 
ated liposom~,~ o?t Q'totoxicity 
Fig. 5 presents the relation between the extent of 
MDP-induced tmnor cytotoxicity of the ainount of 
macrophage-~lssociated liposomal PS or DPPG. For 
PC /DPPG liposomes, amounts of up to 31)0 nmol of 
DPPG (i,e,, ~ls much as 1000 nmol of total lipid) 
taken np per mg cellular protein in 24 h did not 
g, 
30 . "\ ~ A  
"~----  ~- -~ ' - i  ± 
25 50 75 100 125 150 175 200 
nmol nposomal PS I ml 
Fig. 3. hlhibition ol" liposomaI-MDP induced tumor cytotoxicity 
~ilh increasing amounts of lipo~omaI-PS. Liver macrophages 
~ere cocuhured with ~H-10beled tumo, ;.ii~ in the pre~ence of
MDP encapsulated in tbur differently ,umposed liposomes. The 
lipo,(~mex were composed of eggPC/choi/PS in ratios nf 9:10: I
Icircle, k 8:111:2 (squares). 7:10:3 (triangles) and 6:10:4 (inverted 
irlangles). Open symbols represent lysis induced with 1.25/xg/ml 
of MDP and I} 25 ,o.molflml of ttltal lipostmlal lipid: half-filled 
~ynabol~ lysis induced with 2.5 ~g/nd of MDP and 0.5/xnlol/ml 
of lipid and filled symbols lysi~ induced with 5 pg/ml of MDP 
and I #mill/nil of lipid. Cytolysis was determined as described 
in the legend t~[ Fig. 1. Given is Ihe mean percentage of 
cytol3sis. Bar~. S.D. " significantly dift~rent (P < n.on25) from 
¢yttqy~is induced by the same 3illoun[ of total lip~)soulal lipid of 










.nlol total lipid par ml 
f. Ottemett et .L / BiochPnil'a el Bi.physica A('tl112,~5 (19q61219 22,~ 
suffices to induce activation of the cells, or during the 
44 h of subsequent cocultivation of macrophages 
with tumor cells (Figs. 6 and 71. Liposomes (PC/PS  
(7:3): 0.5 gmol /ml )  which are present only during 
the 4-h incubation with MDP or LPS did not reduce 
the induced tumor eell lysis significantly, neither for 
MDP nor fi~r LPS (bars C versus E in Figs. 6 and 7. 
respectively). Liposomes present during the '44-h co- 
culture period, on the other hand, significantly inhib- 
ited the lyric activity of the maerophages. This was 
true irrespective of the MDP/LPS  exposure period: 
2000 bars D and F. representing the presence of the activa- 
tor during the initial 4-h period, or bars B with the 
activator present during the 44-h co-cultivation pe- 
riod. These results clearly indicate that the inhibitory 
effect of the PS develops during the period after the 
inilial ,,loges of activiation. Interestingly, the lipo- 
somes do not have to be present simultaneously with 
the activators to exert their inhibitory action: the 
development of a full eytotoxie slate initiated during 
a 4-h pro-incubation with the activator can still be 
effectively blocked by PS liposomes during the sub- 
Fi t, 4. Uptake of liposame~ by rat liver macrophages. Lil:osomes 
composed of eggPC/PS (7:3~(~11), eggPC/'PS (9:1~,O) or 
eggPC/DPPG (7:3) (• )  were labeled with [~H]CE. Increasing 
amounts tff ligosomal lipid were added IO macrophage rpc.nnl~ly- 
ors and incubaled for 24 h at 37°C in medium containing I11~/~ 
FCS, Further details in Solution 2. Data are expressed I~, mean 
uplake in nmot' of tol~l lipid per mg of cellular pr, uein of 
duplicate ur triplicale determinations, Bars. S,D. 
significantly inhibit tumor cell lysis. By contrast. PS 
(in PC/PS  (7:3) lipn~omes) taken up by the cells 
showed an increasing inhibition of tumor cell lysis 
with increasing amounts of lipid taken up. Inhibition 
induced by up to 50 nmol cell-associated PS (in 300 
nmol PC /PS  (9:1) liposomes) was not significant 
(not shown), The effects of larger amounts of PS 
uptake by means of these liposomes could not be 
gncasurud because of toxic cfl~cts on the cells due to 
the amounts of lipo,,,omes required to achieve such 
uptake values, which caused the cells to detach fi'om 
the culture dishes. The same was observed f, ar PC /PG 
(7:3) liposomcs beyond 300 nmol PG taken up per 
mg protein (squares). 
3.5. h!fluence o f  time ¢~f addition em the inhibito O' 
~:ff ,,,.t (~/' PS  
In the e×perimems described abow, both Ihe im- 
munomodulators and the liposnmes were present all 
alnng lhe activation period of the mucrophages and 
the '~umor cell lysis period. To gain more insighl in 
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Fig. 5. I.hihition of m:scmphage-mediated lumnr cell lyxis in 
lehdiun to Ihe amotlrU tt[ PS ur DPPG ,ixsuciated to the 
mlt¢lophllgeS. Withill une experiment liptlsome uptake and the 
¢lt~Cl tit' lipost,mex on macrophage tumor cytotoxicity was deter- 
nlined, Pan ot the m:tcrophage~ ~ere incub~lted with [sHICE 
c.:llaining lipt~sltnle, to determine tlptake, :t~ dexcril~',J in the 
legend ol Fig, 4. The remaining cells were incub:lted ~ilh MDP 
It(10 #g/mr) in the pre~ence of eggPC/PS (7:3) COl or 
cggPC/DPPG {7:3) (111 liposonles and ~:uculturt.d with C26 
cell, as described in the legend or Fig. I. Given ix the mean 
pe~'enl~lge tff inhlbhhm tff MDP-induced tumor cytotoxicity or 
were exposed to PS-liposoBleS either dnring the 4-h three i.divkhml eqlefiment,, B;lr,, 5;.13. ,ignifie:mtl.v diffl:reut 
period before tile tumor cells ',,,'ere added, which ( I' < (11)5) b't~nl c)tul)~is itldueed b} MDP alune 16W:~). 
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4 
N 20 -, 
0 - 4 hr: med ium MOP MOP+l ip  
4 - 48  hr: MDP MOP+bp medium l lp med ium ap 
Fig. 6. Effect of PS-lipesomes on MDP-induced tumor c~toloxic- 
iry: presence of PS.lipnsomes during the 4-h a~ti~ fion ptMnd or 
the 48-h maerophage/tumor cell coculture. Maerophages were 
incubated with medium, MDP (10~) ~g/mD or MDP + lipz)st)mc~ 
(POPC/DOPS 7:3; 0.5 gmol/ml). After 4 h the supernatant 
with the lipesomes w~.~ removed and ~H-labeled tumor ceils were 
added together with MDP. liposome~.. MDP+liposontes or 
medium alone. After 48 h 3H-relettse into Ihe supenlatant was 
determined. Given is Ihe mean percenlage of cytolysis of Ikmr 
experiments. Ba~. S.D. 
sequenl 44-h period, when the activator (MDP or 
LPS) is no longer present (bars D). 
The lack of effect of ihe presence of PS-liposomes 
during the first 4 h (bars E) cannot be ascribed to an 
insufficient amount of cell-associated liposomes ince. 




o - 4 hrO: med ium LPB LP$+I Ip  
4 -411hr :  LPS LPS+I Ip  med ium liT) med ium l ip 
Fig, 7, Effect of PS-liposomes on LPS-induced tumor cytt)toxlc- 
ity: presence of PS-Iiposomes during the 4-h activation period or 
the ~-h macrophage/tumor cell coculture. The experiment was 
perlbrmed as described in the legend of Fig. 6 with LPS (100 
ng/ml) nr LPS + lipQsomes (POPC/DOPS = 7:3:0.5 .~mol/ml). 
Giw.n is the mean percentage of a typical experiment in tripli- 
cate. Bars, S.D. 
following a 4 h incubation with 0.5 / .tmol/ml of 
PC /PS  (7:3) liposomes, approx. 1600 nmol of lipo- 
somes are taken up by the macrophages per mg cell 
protein (not shown). As shown in Fig. 5. MDP-in- 
duced minor cell lysis is strongly inhibited when such 
an amount of PS-liposomes is taken up by the ceils. 
3,6. Effect o[ preincnbafion w#h PS-liposomcs 
To further investigate chronological aspects og the 
inhibitory cffi:cf of PS-liposomes. we exploited our 
earlier observation that macruphages preincubated 
with MDP tbr 24 h before addition of tumor cells 
have lost their minor cytotoxi¢ state and cannot be 
reacti',ated for at least 48 h [9], In the present study 
macrophages were preincubated ibr 24 h with MDP 
and/or  PC/PS- l iposomes. After 24 h, the media 
were removed and tumor cells were added in fresh 
medium together with MDP (Fig. g). As we previ- 
ously fotmd, preael[vation with MDP resulted in a 
steep drop in MDP-induced tumor cell lysis (bar B 
vs. bar A, P < 0.001"1. The presence of PS-containing 
liposomes during the preincubation period with MDP, 
was able to partially prevent his drop (bar D vs. bar 
B; P < 0,002), These data, combined with ~he data 
shown in Figs. 6 and 7, indicate thal the larger part of 
the PS effect on the activation process is achieved 
o 1 40 
~3e 
u 20  
10  
0 
0 - 24  hr: med ium MDP tip MDP + l ip 
24  - 72 hr: MOP MDP MDP MDP 
Fig. 8. Effec~ of Pg-liposolnes on reaclivation of liver 
mactophages with MDP. Macrophages were incubated with 
medium. MDP (100 Fg/mD, lipesomes (POPC/DOPS = 7:3: 
0.5 /xn~ol/ml) or MDP+liposnmes. After 24 h the supematant 
was removed and H-labeled tumor cells were added together 
with MDP. ',tier 48 h 3H-release into the supernatant ~as 
determined. Given is the mean percentage of cytolysis of a 
typical expeliment in triplicate. Bars. S.D. 
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between 4 and 24 h after the addition of MDP to the 
maemr:,hages. 
Liposomes alone for 24 h did not have a signifi- 
cant effect on the cytotoxic activity of the 
macrophages (Fig. 8, bar C). 
Similar results were obtained for activation with 
LPS (not shc~wn). 
4. Discussion 
PS-containiug liposomes were found to interfere 
with the development of MDP- and LPS-induced 
liver macrophage cytotoxicityr Our results suggest 
that the inhibitory effect of PS-llposomes involves 
the later stage(s) in the activation process rather than 
the initial stage (up to 4 h) or lhe actual cyt,.Jlytlc 
process. Inhibition is apparently not related to the 
amount of liposomes taken up by the macrophages. 
since mac!ophages incubated for 24 h with liposomes 
before activation with MDP express full tumor cyto- 
toxicity. 
Gilbreath et al. showed that PS-coatahting lipo- 
somes inhibil lymphokine-induced maerophage mi- 
crobicidal activity against Le ishmania  major  [ I 0-12]. 
They observed, however, no inhibition of lym- 
phokine-induced inacrophage tumor cytotoxic activ- 
ity. In addition, in their studies it was concluded that 
PS-liposomes interL~re with one or more early events 
in the induction of microbicidal macrnpbuges [10]. 
while we conclude from our observations that PS 
rather affect'.; later activation events. Observations by 
Keller et al. [13] may very well explain the apparent 
discrepancy between the results with lymphokines as 
described by Gilbveath e~ al. [!0] and .:;ur results 
using MDP or LPS as immunnmodulalors. Keller e[ 
al. showed that lymphokines and bacteria, bolh of 
which induce lumoricidal ;~ctivity. trigger different 
secretory responses in bone-marrow-derived n'lononu- 
clear phagocytes. Inducti~m of lumoricidal activity by 
lymphokines was nol associated with an enhanced 
secretion of IL-6 a!~d PGE2 sccretitm while heat-killed 
intracellular bacteria resulted in a markedly enhanced 
secretion of these products [13]. Similarl,'. we fnund 
that MDP and LPS, both originating from bacterial 
cell wall material, induce secretion of several cy- 
tokincs [14]. 
Although the results presented in Fig. 5 ,;lat~w a
good correlation between extent of inhibition and 
amount of PS taken up by the macrophages, this does 
not exclude the possibility that the inhibitory effect is 
accomplished by extracellulat FS because high up- 
take necessarily means high medium concentration as 
well. Compatible with an extracellular target fol the 
PS effect appears the observation that the amount of 
t°S liposomcs taken up during a 24-h incubation is 
unable to cause any inhibition of activation by MDP 
during a subsequent 48-h incubation period (Fig. 8, 
bar C). Also in that case, however, the signal given to 
the cell by extracellular PS (or a metabolite) would 
have to be ;ransduced to an intracellular site because 
the activation induced by MDP or LP$ during a 4-h 
preincubation can still be abolished by PS liposomes 
added after the activators have been removed (Figs. 6 
and 7. bars D). We have. at p,'esent, no compelling 
evidence to favor either an intracellular or an extra- 
cellular site of action of PS. Also if n PS metabolite 
were involved, it could be formed both intra- and 
extracellularly. 
In either case, it is clear that sustained availability 
of PS is required (Figs. 6 and 7, bars E vs. bars F). 
This might also explain the direction of the effect of 
cholesteroh whenever it had an effect on the PS-in- 
duced inhibition, it was an enhancement. Cholesterol 
is known to retard enzymatic degradation of liposo- 
mal phospholipids [ 15]. 
We have shown previc, usly that the activating po- 
tency of LPS towards liver maerophages i dimin- 
ished 20 IO0-fold by encapsulating it in liposomes 
[16]. We attributed this to intralysosomal inactivation 
of LPS. It is unlikely that the inhibitory activity of PS 
on LPS-induced cytotoxieity in the present experi- 
ments is caused by spontaneous association of the 
LPS with the liposomes such that it is taken to the 
lysosomal compartment and inactivated: liposomes 
present dnring a 4-h incubation with LPS just slightly 
reduced The induced tumor cell lysis (Fig. 7. bars C 
versus El, while the inhibitory el]~cl was clearly 
utanilest when the liposomes were added after the 
LPS had been removed (Fig, 7, bar D). Monastra et 
al. [17] showed that liposomes containirg PS signifi- 
cantly reduced the endotoxin-indueed TNF sernm 
level in mice and rabbits. Also in this study a direct 
LPS-liposome interaction at the site of iniection or in 
plasma could be excluded. 
PS h~ls been shown to possess imlnunosuppressive 
f I)~¢emltl ~r , L /  Bu,chinli(~t e! tiio(~h~ic~ ,h'ta 12S~ r 1996J 2[0 22,~¢ 
properties. For example, it prevents the primary hu 
moral immune response in mice and in cultured 
spleen cells it inhibits the response to mitogens acti- 
vating the T-cell antigen receptor [18]. PS-liposoares 
reduced nitric oxide synthesis from peritoneal 
macrophages treated with IFN-r. IFN-r /MDP and 
IFN-'r/TNF-a' and reduced the IgG response to 
bovine serum albumin [19]. Caldcron c ta l .  [20] 
demonstrated that the impaired ability of macrophagcs 
from mice bearing DI-DMBA-3 mammary tumors in 
produce nitric oxide in response to LPS could be 
ascribed to PS overexpressed/shed by these tumor 
cells. It has also been shown that orally administered 
PS suppresses antigen-specific lgM production against 
sheep red blood cells, intubated intragastrically [21]. 
In the latter study the authors postulate that PS. 
which is situated predominantly on the inner snrface 
of the eukaryotic ell membrane, is released after the 
destruction of cells, thus controlling and limiting 
inflammation. Fadok et al. [22.23] showed that PS is 
exposed on the surface of apoptotic lymphocytcs and 
thereby triggers specific reeognitio0 and removal of 
such cells by macrophages, Also the observation that 
PS-liposomes block the recognition of sickled red 
cells expressing PS externally by macrophages, led to 
the hypothesis that macmphages might specifically 
recognize PS [24,25]. 
As shown by Gilbreath et al. [I I], the inhibition of 
microbieidal activity was directly influenced by 
changes in the phospholipid head group as well as by 
the number of unsaturated bonds in the phospholipid 
acyl groups. Progressively increasing unsaturation of 
the acyl moieties optimized the inhibitory effect of 
the phospholipids. Similarly, we found that inhibition 
of MDP-induced macrophage activation by DOPS 
was slightly lower than that caused by brain-PS. A 
potential involvement of phospholipase A2 activity is 
suggested by the observation that this enzyme is 
strongly influenced by the degree of unsaturation of 
the sn-2 fatty acid in the substrate [26] and that 
activated macrophages display increased levels of 
phospholipase activities [27]. Bellini and Bruni [28] 
showed that the inhibitory action on mitogcn-induced 
T-cell activation of PS requires a serum protein which 
displays phospholipase A activity specifically to- 
wards PS. Upon incubation of this protein with PS, 
lyso-PS and the c is -unsaturated  fany acid are re- 
leased. The latter was found to be mainly respon~,iblc 
for the PS-induced inhibition of mitogen-lndueed T-
ceil activatk~n. 
We ha~ e no satisfactory explanation for our obser- 
",atioit oil dlc enhanced uptake of lipnsomes contain- 
ing 31) mol% of PS compared to liposomes contain- 
ing 10 m01~'~ of PS or 30 reel% of DPPG. At present 
we arc ~,tudyittg ~his phenonteuon i  more detail. 
The results presented in this paper demonstrate he 
intporlance of the selection of components t-or the 
fi~rmulation of carrier liposomes in delivery of im- 
rnunoraodulatory agems. To explain the inhibitory 
efl~ct of PS, we Favor a pharmacological interference 
tff thi~, phospholipid or one of its metabolites with the 
activation princess, probably following internalization 
and inu'acellular processing by the macrophages. 
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